Evaluation of the Relationship between Pathology Results and Pain Scores in Patients Who Underwent Transrectal Ultrasound-Guided Prostate
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 3
Abstract
Objectives: In this study, we assessed the relationship between pain scores and the pathology results of patients who underwent transrectal ultrasound-guided prostate biopsy (TRUS-PBx). Materials and Methods: A total of 198 patients who underwent prostate biopsy between October 2014 and April 2015 due to abnormal digital rectal examination findings and/or high prostate-specific antigen (PSA) levels (≥2.5 ng/dL) were included in this study. Before the biopsy procedure, all patients underwent finger-guided transperineal periprostatic block with 10 mL of 2% prilocaine. A 10-point linear visual analogue scale (VAS) was used to assess the pain arising from probe insertion (VAS-1) and prostate sampling (VAS-2). After receiving the pathology results, the patients were grouped according to the presence of prostate cancer: Group 1: patients without prostate cancer and Group 2: patients with prostate cancer. Results: The mean age of the patients was 64±7.3 (43-83) years, and the mean PSA value was 12.5±18.3 (0.6-142) ng/dL. Prostate cancer detection rate was 22.7%. The mean VAS-1 score in Group 1 and group 2 was 1.6±1.8 and 2.0±2.5, respectively (p=0.209). The mean VAS-2 score in Group 1 and Group 2 was 2.5±2.4 and 2.6±2.6, respectively (p=0,725). Conclusion: The pain felt during TRUS-PBx is not related with the presence of prostate cancer on biopsy pathology.
Authors and Affiliations
Deniz Bolat, Mehmet Erhan Aydın, Bülent Günlüsoy, Tansu Değirmenci, Yusuf Kadir Topçu, İbrahim Küçüktürkmen, Yasin Ceylan, Ertuğrul Şefik
Keywords
Related Articles
- EP ID EP228281
- DOI 10.4274/uob.666
- Views 91
- Downloads 0
Positron Emission Tomography in Renal Cell Carcinoma
Renal cell carcinoma is the most common solid kidney tumor. Conventional methods such as computed tomography and magnetic resonance imaging are usually chosen for diagnosis, staging, and evaluating recurrence and treatme...
What is the Prostate-Specific Antigen Cut-Off Value to Detect Clinically Significant Prostate Cancer According to Age in Turkey?
Objective: To detect a prostate-specific antigen (PSA) cut-off for clinically significant prostate cancer (csPCa) according to age in Turkey. Materials and Methods: A total of 532 men who had transrectal ultrasound-guid...
Effects and Mechanisms of Checkpoint Inhibitors (CTLA-4, PD-1 and PD-L1 Inhibitors) as New Immunotherapeutic Agents for Bladder Cancer
Since intravesical Bacillus Calmette-Guerin (BCG) began to be used for bladder cancer, our understanding of the importance of immune mechanisms in bladder cancer has steadily grown. With developments in immunotherapy in...
Do Length and Tumor Grades of Positive Surgical Margin Have an Impact on Biochemical Recurrence After Prostatectomy?
Objective: Biochemical recurrence (BCR) does not occur in all patients with surgical margin (SM) positivity after radical prostatectomy (RP). The aim of our study is to evaluate the effect of additional features such as...
A Rare Case: Contralateral Testicular Seminoma Accompanied by Right Undescended Testicle and Right Inguinal Hernia with Ipsilateral Renal Agenesis and Seminal Vesicle Agenesis
Due to the close relationship between the male reproductive system and the urinary system, both embryological and congenital anatomic anomalies of these systems are often seen together. Seminal vesicle agenesis is a rela...